NCT05680584

Brief Summary

Comparison between the effect of oral Melatonin and Hydroxyzine for Preventing Preoperative Anxiety in pediatric Patients Undergoing Adenotonsillectomy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

December 27, 2023

Status Verified

December 1, 2023

Enrollment Period

12 months

First QC Date

December 19, 2022

Last Update Submit

December 25, 2023

Conditions

Keywords

MelatoninHydroxyzinePreoperative AnxietyPediatricAdenotonsillectomy

Outcome Measures

Primary Outcomes (2)

  • Ease of parenteral separation.

    Recorded as excellent, good, fair, or poor when the child is separated from the parent

    20-30 minutes after administration

  • The compliance to anesthesia induction in pediatric patients.

    Assessed by a modified Yale preoperative anxiety scale, the range is from 5 to 22, the lower score is better

    one hour after administration

Secondary Outcomes (2)

  • Assessment of postoperative pain

    immediately before and at induction procedure

  • First analgesic request

    Three hours postoperative

Study Arms (3)

Melatonin

ACTIVE COMPARATOR

Preoperative oral melatonin 0.1mg/ kg in 10ml apple juice one hour before induction of anesthesia

Drug: Melatonin 3 MG

Hydroxyzine

ACTIVE COMPARATOR

Preoperative oral hydroxyzine 1mg/ kg in 10ml apple juice one hour before induction of anesthesia

Drug: Hydroxyzine Pill

placebo

PLACEBO COMPARATOR

10ml apple juice one hour before induction of anesthesia

Other: Placebo

Interventions

0.1 mg/ kg melatonin in 10 ml apple juice 1 hour before induction of anesthesia

Also known as: Melatonin
Melatonin

1 mg/ kg hydroxyzine in 10 ml apple juice 1 hour before induction of anesthesia

Also known as: Atarax 10mg
Hydroxyzine
PlaceboOTHER

10 ml apple juice 1 hour before induction of anesthesia

placebo

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA: class l
  • Sex: male and female
  • Age: from 3 to 10 years old
  • Children scheduled for adenotonsillectomy

You may not qualify if:

  • All children with a history of chronic illness, or developmental delay were excluded from the study
  • History of an autoimmune disease
  • Concurrent use of immunosuppressive treatment
  • Sleep disturbances, speech or communication problems
  • allergic to hydroxyzine, cetirizine, or other derivatives of piperazine, aminophylline, and ethylenediamine.
  • hydroxyzine is contraindicated in patients with acute porphyria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sarah Omar

Al Minyā, 61111, Egypt

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Interventions

MelatoninHydroxyzine

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPiperazinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Sarah Omar

    Minia University

    STUDY DIRECTOR

Central Study Contacts

Sarah Omar, M.D.

CONTACT

Hanafy

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Three study groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

December 19, 2022

First Posted

January 11, 2023

Study Start

February 1, 2023

Primary Completion

January 30, 2024

Study Completion

January 30, 2024

Last Updated

December 27, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

May share when the study is completed

Locations